Key facts for Q9966
- Billing unit
- 1 ML
- Locm 200-299mg/ml iodine,1ml
- ASP payment limit
- $0.421
- October 2026; -3.2% vs July 2026
- Practitioner MUE
- 250
- MAI 3
- OPPS status
- SI N
- NCCI exposure
- 6 col-2 pairs
- 100% allow a modifier
- Coverage articles
- 0
- none list this code
TL;DR
HCPCS Q9966 is the Level II code for Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml, billed per 1 ML. The Medicare Part B ASP payment limit for October 2026 is $0.421 per billing unit, down 3.2% from July 2026. The practitioner MUE allows up to 250 units per date of service (MAI 3), so a full 250-unit day is $105.25 at the current limit. Under OPPS it carries status indicator N. Diagnostic agents are usually packaged under OPPS (status N) in the hospital outpatient setting, so separate payment applies mainly in the physician office under Part B. The ASP crosswalk maps 21 NDCs to it, sold as Isovue-200, Isovue-250, Isovue-M-200 by Bracco Diagnostics Inc., GE Healthcare Inc., FreseniUS Kabi USA, LLC. It is the bundled column-2 code in 6 NCCI pairs, most often with Q9958, Q9960, Q9961. No current Billing and Coding Article lists Q9966, so coverage follows the FDA label, compendia and any applicable NCD.
Medicare Part B payment limit (ASP)
CMS sets the Part B payment limit for Q9966 at $0.421 per 1 ML for October 2026, derived from manufacturer average sales price plus 6%, compared with $0.435 in July 2026. Beneficiary coinsurance is 20%.
| Quarter | Payment limit | Per | Coinsurance |
|---|---|---|---|
| October 2026 | $0.421 | 1 ML | 20% |
| July 2026 | $0.435 | 1 ML | — |
NDC to HCPCS billing-unit conversion
The October 2026 ASP crosswalk maps 21 NDCs from 4 labelers to Q9966. Report the NDC in the claim's drug segment and bill the number of Q9966 units that equals the quantity administered divided by 1 ML; the last column gives units per full package.
| NDC | Drug name | Labeler | Package size | Billing units / package |
|---|---|---|---|---|
| 00270-1314-15 | Isovue-200 | Bracco Diagnostics Inc. | 200 × 10 | 2000 |
| 00270-1317-02 | Isovue-250 | Bracco Diagnostics Inc. | 100 × 10 | 1000 |
| 00270-1411-11 | Isovue-M-200 | Bracco Diagnostics Inc. | 10 × 10 | 100 |
| 00270-7250-10 | Iomeron | Bracco Diagnostics Inc. | 100 × 56 | 5600 |
| 00407-1412-10 | Omnipaque 240 | GE Healthcare Inc. | 10 × 10 | 100 |
| 00407-1412-20 | Omnipaque 240 | GE Healthcare Inc. | 20 × 10 | 200 |
| 00407-1412-30 | Omnipaque 240 | GE Healthcare Inc. | 50 × 10 | 500 |
| 00407-1412-33 | Omnipaque 240 | GE Healthcare Inc. | 100 × 10 | 1000 |
| 00407-1412-34 | Omnipaque 240 | GE Healthcare Inc. | 150 × 10 | 1500 |
| 00407-1412-35 | Omnipaque 240 | GE Healthcare Inc. | 200 × 10 | 2000 |
| 00407-1412-38 | Omnipaque 240 | GE Healthcare Inc. | 50 × 10 | 500 |
| 00407-2222-16 | Visipaque 270 | GE Healthcare Inc. | 50 × 10 | 500 |
| 00407-2222-17 | Visipaque 270 | GE Healthcare Inc. | 100 × 10 | 1000 |
| 00407-2222-19 | Visipaque 270 | GE Healthcare Inc. | 150 × 10 | 1500 |
| 00407-2222-21 | Visipaque 270 | GE Healthcare Inc. | 200 × 10 | 2000 |
| 65219-0381-10 | Iodixanol | FreseniUS Kabi USA, LLC | 100 × 10 | 1000 |
| 65219-0381-50 | Iodixanol | FreseniUS Kabi USA, LLC | 150 × 10 | 1500 |
| 70436-0124-52 | Iopamidol | Slate Run Pharmaceuticals | 20 × 10 | 200 |
| 70436-0124-82 | Iopamidol | Slate Run Pharmaceuticals | 10 × 10 | 100 |
| 70436-0125-82 | Iopamidol | Slate Run Pharmaceuticals | 50 × 10 | 500 |
| 70436-0211-80 | Iopamidol | Slate Run Pharmaceuticals | 50 × 1 | 50 |
Medically Unlikely Edits (MUE)
CMS publishes 2 MUE values for Q9966. For practitioners the limit is 250 units per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.
| Setting | MUE (units/DOS) | MAI | CMS rationale |
|---|---|---|---|
| Practitioner services | 250 | 3 Date of Service Edit: Clinical | Prescribing Information |
| Facility outpatient hospital | 250 | 3 Date of Service Edit: Clinical | Prescribing Information |
MUE for Q9966 in every setting opens the lookup with this code filled in, next to any other code on the same claim.
NCCI edits and add-on relationships
In the practitioner PTP file v323r0 (effective October 1, 2026), Q9966 is the column-2 code in 6 active pairs, 100% of which allow a modifier (indicator 1), and the column-1 code in 4. 0 historical pairs have been deleted over time. CMS's most frequent rationale: Mutually exclusive procedures.
When billed with these column-1 codes, Q9966 is the bundled component unless the pair allows a modifier and the documentation supports a distinct service.
The counts above are exposure, not answers for a specific claim. Check Q9966 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.
Q9966 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.
Medicare coverage articles
No current Billing and Coding Article lists Q9966 in its HCPCS table. Coverage then follows the drug's FDA label, compendia and any National Coverage Determination; check the Medicare Coverage Database before administering off-label.
Hospital outpatient (OPPS) status
In the October 2026 OPPS Addendum B, Q9966 carries status indicator N. Status N means payment is packaged into the associated procedure and no separate OPPS payment is made.
Ambulatory surgical center (ASC) payment
In the October 2026 ASC Addendum BB (covered ancillary services), Q9966 carries payment indicator N1, which CMS defines as "Packaged service/item; no separate payment made". An N1 drug is packaged in the ASC: the facility receives no separate payment because the surgical procedure's rate already includes it.
Common denials for Q9966 and how to prevent them
For teams evaluating QuickIntell software
Evaluate a coding workflow for Q9966
Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.
Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.
In QuickIntell research
- 2026 Q4 most-bundled codes report: Q9966 is the column-2 code in 6 active practitioner NCCI pairs, one of 12 Part B drug codes that NCCI bundles at all.
- J codes by drug name: Every code for the same drug, generic or brand, in one A-Z index.
Frequently asked questions — HCPCS Q9966
What does HCPCS code Q9966 describe?
Q9966 is defined by CMS as "Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml". Each billing unit represents 1 ML, so the units reported on the claim must equal the dose administered divided by that unit.
Is Q9966 a CPT code?
No. Q9966 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as low osmolar contrast material; CPT codes are five-character codes maintained by the AMA. On a Part B claim Q9966 reports the drug itself in 1 ml units, and the administration is billed on its own line.
What is the Medicare reimbursement for Q9966 in October 2026?
The ASP-based payment limit is $0.421 per 1 ML, with 20% beneficiary coinsurance. The July 2026 limit was $0.435. Commercial payers use their own fee schedules.
How many units of Q9966 can be billed per day?
The practitioner Medically Unlikely Edit is 250 units per date of service with adjudication indicator 3 (Date of Service Edit: Clinical). MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "Prescribing Information" as the rationale.
Which NDCs map to Q9966?
The October 2026 ASP crosswalk lists 21 NDCs from 4 labelers: Isovue-200 (Bracco Diagnostics Inc.); Isovue-250 (Bracco Diagnostics Inc.); Isovue-M-200 (Bracco Diagnostics Inc.); Iomeron (Bracco Diagnostics Inc.). For example NDC 00270-1314-15 (package size 200) equals 2,000 billing units of Q9966.
Does Q9966 have NCCI bundling edits?
In the v323r0 practitioner PTP file, Q9966 appears as the column-2 (bundled) code in 6 active pairs and as the column-1 code in 4. 100% of the column-2 pairs allow a modifier (indicator 1). The most frequent column-1 partners are Q9958, Q9960, Q9961, Q9962, Q9963, and CMS's leading rationale is "Mutually exclusive procedures".
Sources
Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.
- HCPCS Level II alpha-numeric file, October 2026Version October 2026 · effective 2026-10-01 · file HCPC2026_OCT_ANWEB_09232026.txtSHA-256 c25240c63108756d…
- Medicare Part B Drug Payment Limit File, October 2026Version October 2026 · effective 2026-10-01 · file section 508 version of October 2026 Medicare Part B Payment Limit File 091626.csvSHA-256 508fba376a29e099…
- Medicare Part B Drug Payment Limit File, July 2026Version July 2026 · effective 2026-07-01 · file section 508 version of July 2026 Medicare Part B Payment Limit File updated 082026.csvSHA-256 13bb5b644b92b574…
- ASP NDC-HCPCS Crosswalk, October 2026Version October 2026 · effective 2026-10-01 · file section 508 version of October 2026 ASP NDC-HCPCS Crosswalk 091126.csvSHA-256 5cb78f0c2ee786ba…
- NCCI MUE table, practitioner services, effective 2026-10-01Version 2026 Q4 · effective 2026-10-01 · file MCR_MUE_PractitionerServices_Eff_10-01-2026.csvSHA-256 ef038efaf902b7bd…
- NCCI MUE table, facility services, effective 2026-10-01Version 2026 Q4 · effective 2026-10-01 · file MCR_MUE_OutpatientHospitalServices_Eff_10-01-2026.csvSHA-256 3af9f4e99cc587e2…
- NCCI MUE table, dme services, effective 2026-10-01Version 2026 Q4 · effective 2026-10-01 · file MCR_MUE_DMESupplierServices_Eff_10-01-2026.csvSHA-256 6fa4fbba852f7b74…
- NCCI PTP edits, practitioner, v323r0 (four files)Version v323r0 (2026 Q4) · effective 2026-10-01 · file ccipra-v323r0-f1.TXTSHA-256 7793c0b6686c1e22…
- NCCI Add-On Code edits, effective 2026-10-01Version 2026 Q4 · effective 2026-10-01 · file AOC_V2026Q4-F-MCR.xlsxSHA-256 eabb519623134549…
- OPPS Addendum B, October 2026Version October 2026 · effective 2026-10-01 · file 508-compliant-version-2026_October_Web_Addendum_B.09.28.26.csvSHA-256 6ad7393a318bf1b9…
- ASC Addendum BB (covered ancillary services), October 2026Version October 2026 · effective 2026-10-01 · file Oct 2026 ASC BB.txtSHA-256 63cdd7c72aba7a25…
- Medicare Coverage Database, current Billing and Coding Articles exportVersion MCD release 2026-11-12 · effective 2026-11-08 · file article.csvSHA-256 b475751458564786…
Disclaimer
This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.
Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.